Us Neurosurgical Holdings Inc. (USNU)

Overview

U.S. NeuroSurgical Holdings, Inc. is a pioneering healthcare company dedicated to advancing brain treatment technologies. Founded in 1993 and headquartered in Rockville, Maryland, the company, through its subsidiaries, specializes in owning and operating centers that focus on stereotactic radiosurgery—a non-invasive treatment method. By leveraging cutting-edge gamma knife technology, U.S. NeuroSurgical Holdings, Inc. has established itself as a leader in treating complex brain tumors and other cerebral malformations, offering patients effective alternatives to traditional invasive surgery.

Products and Services

• Gamma Knife Technology

The cornerstone of U.S. NeuroSurgical Holdings, Inc.'s treatment offerings, Gamma Knife technology, represents a sophisticated form of stereotactic radiosurgery. Unlike conventional surgery, which requires incisions, Gamma Knife procedures are non-invasive. This technology precisely targets and irradiates brain tumors or malformations with high doses of radiation, sparing surrounding healthy tissue. Its precision and non-invasiveness make it a preferred choice for patients with certain conditions that are difficult or impossible to reach via traditional surgery.

• Stereotactic Radiosurgery Centers

U.S. NeuroSurgical Holdings, Inc. operates a network of specialized centers equipped with state-of-the-art Gamma Knife technology. These centers are at the forefront of brain treatment, staffed by multidisciplinary teams of experts dedicated to providing targeted, patient-centric care. The centers offer a comprehensive approach to treatment, starting from initial consultations to post-treatment follow-ups, ensuring that each patient receives personalized care tailored to their specific condition and needs.